Info

Alseres Pharmaceuticals, Inc. is a biotechnology company engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system (CNS). The Company's clinical and preclinical product candidate pipeline is based on three technology platforms: regenerative therapeutics program, molecular imaging program and neurodegenerative disease program. Formerly known as Boston Life Sciences, Inc. until its name change on June 7, 2007, the Company has devoted substantially all of its efforts to business planning, raising financing, furthering the research and development of its technologies, and corporate partnering efforts.(Source: 10-K)